Many biopharma companies are digitally transforming their supply chains1 to help prepare for future challenges. Over the past year, we have explored how digitizing processes and information can help supply chains become more resilient and sustainable. In this fourth and final installment of our biopharma supply chain series, we turn our attention to the transformation’s impact on the workforce. Workers are not just being affected by this change—they are the agents enabling and implementing it, so they must adapt to using the latest technologies in their roles.
In 2023, the Deloitte Center for Health Solutions surveyed 105 biopharma supply chain leaders to understand their perspectives on the workforce’s role in digitizing supply chains. To delve deeper into the insights we gathered, we interviewed six industry leaders in 2024. Our research explored pressing challenges and skills gaps that today’s biopharma supply chain leaders face, offering strategies to help overcome these hurdles. We learned that although some workforce challenges and strategies seem to be specific to the supply chain function, many are relevant across the entire organization
The study participants shared the following key insights that apply to organizations equipping their workers with digital tools and solutions.
To help ensure the workforce is digitally ready, we propose a four-component framework that aligns supply chain objectives with the company’s overarching vision. This involves identifying essential capabilities, managing transitional changes, and emphasizing human-centric skills.2 As the industry progresses toward a digital future, it’s important to identify, develop, and clearly define the career paths (including ones that may seem unconventional) that focus on developing these skills.
Digitalization is reshaping the biopharma industry in profound ways, calling for a digitally fluent workforce. Our analysis of Deloitte Labor Market Intelligence data, updated as of April 2024, provides compelling evidence of this shift. We found that, since 2019, the demand for digital roles in life sciences has surged, with job postings for data engineers and data scientists increasing by 69% and 16% respectively. This transformation is happening in functions across the entire organization, from discovery to commercialization.
Within the supply chain, digital tools and automation can streamline processes, and enhance efficiency, compliance, and product integrity. But capitalizing on these advancements requires having a workforce that’s proficient in technology. Our survey data echoes this sentiment: Eighty-three percent of surveyed biopharma supply chain leaders acknowledged the need to upskill or reskill a significant portion of their supply chain workforce to support digital transformation. They say the top three roles most needed are data scientists and engineers (69%), functional experts (53%), and AI specialists (52%).
Unlike other functions within pharma that yield visible outcomes like scientific discoveries, product approvals, or successful business deals, the contributions of the supply chain workforce might not always be top of mind. It’s often during disruptions that the important nature of supply chain work becomes evident.3 These professionals manufacture, package, and transport temperature-sensitive products; source scarce materials; and manage intricate logistics while adhering to stringent regulatory standards. Technicians play vital roles in operational tasks, while engineers and planners create, optimize, and scale sophisticated processes.4
Biopharma leaders face several challenges as the industry cultivates digital talent, such as competing with other companies, integrating temporary workers, navigating regulations, and preparing for the impending retirement of skilled workers who have a wealth of domain and institutional knowledge.
Most of the industry leaders we interviewed described significant difficulties in attracting and retaining digital talent. They said it’s hard to compete with the tech industry for talent for a variety of reasons like salary expectations. And, internally, candidates with digital skills may gravitate toward high-profile research and development or commercial roles, making it even tougher to secure and retain talent for supply chain functions.
The growing use of a contingent workforce5 in biopharma supply chains can add another layer of complexity. While temporary workers and consultants tend to offer flexibility and access to specialized skills for specific projects, it can be challenging to integrate them and conduct effective knowledge transfer upon project completion.
Regulations tend to present further hurdles when attempting to transform global systems, which is often the case for biopharma supply chains. For example, work councils in parts of Europe require consultations on changes that affect employee roles, such as outsourcing or adopting new technologies and can slow the digitalization process.6 And in other countries, labor laws and trade unions play a significant role in shaping how organizations manage workforce changes.7
Finally, traditional skill sets could be in short supply as the skilled trades workforce approaches retirement.8 As organizations develop ways of documenting and preserving the expertise and institutional knowledge of their seasoned technicians, the end goal is to blend those traditional technical skills with the digital capabilities of the incoming workforce.
Of the three elements of supply chain digital transformation—people, process, and technology—the people factor often receives the least attention.9 Digital transformation should extend beyond implementing technology to redesigning the work and changing the nature of jobs. Companies should have a robust strategy to manage this change proactively and efficiently, cultivate digital skills, and address skills gaps.
A human-centered approach integrates employee experience into the digital strategy from the onset. By viewing changes from employees’ perspectives—including those on the frontline like manufacturing supervisors, product development engineers, and planners—organizations can help ensure not just smoother adoption but also better processes. The leaders we interviewed have only begun to assess the digitally relevant skills and capabilities their workers already have.
As noted by a vice president of human resources at a global biopharma manufacturing firm, assessing skills beyond degrees can be challenging: “We have not cracked that nut yet … Some of it comes from a more robust review of what is that person’s experience and through the interview process, getting underneath what that is.” This approach places humans at the center of digital changes, shaping processes and technology to fit their needs, while equipping them with versatile skills they will need in the future.
This approach involves a clear vision—one that defines and communicates the needs of the future workforce and provides a way to transition from the present. Striking the balance between addressing immediate needs and maintaining long-term focus could be challenging for supply chain leaders. Our research indicates that current initiatives primarily target the immediate and medium-term objectives we’ve listed below. While the interviewees spoke of these strategies within the context of supply chain, they can be relevant to other parts of a biopharma organization.
The goal for many organizations is for digital to become a native capability within the supply chain function. This involves integrating domain knowledge with digital skills, enhanced by human-centered approaches that prioritize people in the design of processes and technology. Without a deliberate strategy, achieving this is cumbersome and costly.
We propose a four-component framework that organizations can use to help align their supply chain talent strategies with their overall enterprise goals, define the necessary capabilities, and manage the transformation effectively (figure 3).
Biopharma supply chain functions are still in the early days of their digital journeys. One fact remains certain: People are the key asset. In this scenario, a well-defined human capital strategy is important. Creating a detailed plan today can help your future workforce meet your company’s needs. With this approach, the supply chain function can be equipped to fulfill its role in the pharmaceutical business: to produce and deliver lifesaving, innovative medicines with quality, consistency, and accuracy.